Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic Beamcath® techniqueFRANSSON, Per; BERGSTROM, Per; LÖFROTH, Per-Olov et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 4, pp 326-333, issn 0284-186X, 8 p.Article

Acute side effects after dose-escalation treatment of prostate cancer using the new urethral catheter BeamCath® techniqueFRANSSON, Per; LÖFROTH, Per-Olov; FRANZEN, Lars et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 6, pp 756-765, issn 0284-186XConference Paper

Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumoursERIKSSON, David; JONIANI, Homa Mirzaie; SHEIKHOLVAEZIN, Ali et al.European journal of nuclear medecine and molecular imaging Print. 2003, Vol 30, Num 6, pp 895-906, issn 1619-7070, 12 p.Article

Apoptosis induced by low-dose and low-dose-rate radiationMIRZAIE-JONIANI, Homa; ERIKSSON, David; SHEIKHOLVAEZIN, Ali et al.Cancer. 2002, Vol 94, Num 4, pp 1210-1214, issn 0008-543X, SUPConference Paper

Cell cycle disturbances and mitotic catastrophes in hela hep2 cells following 2.5 to 10 gy of ionizing radiationERIKSSON, David; LÖFROTH, Per-Olov; JOHANSSON, Lennart et al.Clinical cancer research. 2007, Vol 13, Num 18, issn 1078-0432, 5501s-5508s, 2Conference Paper

The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibodyJOHANSSON, Amanda; ERIKSSON, David; ULLEN, Anders et al.Cancer. 2002, Vol 94, Num 4, pp 1314-1319, issn 0008-543X, SUPConference Paper

Hypofractionated conformal stereotactic radiotherapy for arteriovenous malformations. CommentsLINDVALL, Peter; BERGSTRÖM, Per; GUTIN, Philip H et al.Neurosurgery. 2003, Vol 53, Num 5, pp 1036-1043, issn 0148-396X, 8 p.Article